The possible success of this new therapy, may provide relief to many millions of people who suffer from diabetes type 1.
a number of research groups in the world are focusing on the development of a so-called artificial pancreas, that is; a device that allows you to automate the testing of the glucose, and administer the insulin needed to maintain glucose levels in the blood are adequate.
The artificial pancreas, would be a significant step forward compared to the methods of management of blood sugar in the course, but a solution to the tissue, such as that experienced in San Diego, would allow diabetic patients to lead essentially normal lives.
patients with type 1 diabetes must constantly monitor their blood sugar levels, pricking their fingers and measuring the value of blood glucose of the blood with machines, and must, if necessary, inject insulin.
This routine is particularly difficult for children, who if they fail to properly manage their glucose, they may suffer serious damages.
and Yet, despite years of research, ” says Robert Henry, a medical doctor at the Università of California, San Diego, “non c’è still nothing to offer to the patients.”
Some scientists are now convinced that “the pills in the bag” could represent the therapeutic response in type 1 diabetes.
The “pills” produced in San Diego use of the cells of the pancreas partially ripe, which “triggers” in the body, blocking at the same time, the immune system which destroys.
Thereò thanks to a special membrane that, in the let pass of the substances of which the cells of the pancreas, they need to “trigger”, while blocking the immune system.
One of the critical points of this system, also known as Kevin D’amour, the coordinator of the working group, is that “we do Not know well how hard the effect of a single pill, and for this we expect a number of facilities periodicals”.
Douglas Melton, a biologist of the Università of Harvard, and father of two children with type 1 diabetes, worries that the system ViaCyte may not work.
He thinks that there is the risk that deposits of fibrotic, it can deposit on the capsule, by blocking their capacity to perceive the sugar and release insulin.
operators ViaCyte have in any way responded by saying that “The test that we are conducting is essentially yet, but I think that we will see some benefit to the health of patients”.
Diabetes: nutrition, diet, and activitiesà physics
Diabetes type 1 and 2: it prevents losing weight
Diabetes: examinations recommended
Diabetes: what are the healthy diets
February 25, 2015